Events  Deals  Jobs 
    Sign in  
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit

GRAIL is seeking a Scientist I in the Process Development team at our Menlo Park R&D headquarters to support the Product Development of the Multi-Cancer Early Detection assay as a laboratory-developed test (LDT) & In Vitro Diagnostic Device (IVD). You will develop assay processes to build the laboratory workflow on a high throughput platform using automated workcells & support continuous improvement of the Galleri multi-cancer early detection test. Responsibilities include reagent integration on an automated platform, in-process sample stability, assay guardbanding, development of workflows, & troubleshooting complex problems. The ideal candidate is a curious thinker & passionate problem-solver that possesses experience with automated NGS assays.
Apply To Job
© 2022 GarysGuide      About    Feedback    Press    Terms